Final Report - PONT (Disease therapeutic targets, multidisciplinary parallel validation, accelerated drug discovery)
Project ID: 505781Funded under: FP6-LIFESCIHEALTH
This is the final report for the PONT project, which has been designed to incorporate companies that possess unique technological advantages at specific steps during the development of novel compounds. The report briefly outlines the aims and objectives, before listing the achievements made. It notes that PONT could successfully prove that an aptamer-based approach for new or tricky drug targets can provide compounds with exciting and promising preclinical activity following reasonable timelines.
Download application/zip (59027)
Record Number: 12750 / Last updated on: 2011-04-14